Section Arrow
DERM.NASDAQ
- Journey Medical Corp
Quotes are at least 15-min delayed:2024/11/10 18:36 EST
Last
 5.65
-0.06 (-1.05%)
Day High 
5.76 
Prev. Close
5.71 
1-M High
6.69 
Volume 
67.15K 
Bid
5.63
Ask
5.76
Day Low
5.46 
Open
5.7 
1-M Low
Market Cap 
118.35M 
Currency USD 
P/E 43.92 
%Yield -- 
10-SMA 5.69 
20-SMA 5.83 
50-SMA 5.56 
52-W High 8.11 
52-W Low 2.85 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.13/0.37
Enterprise Value
132.98M
Balance Sheet
Book Value Per Share
0.54
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
79.18M
Operating Revenue Per Share
2.97
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.49-0.06-3.87%-- 
ESPREsperion Therapeutics2.275+0.165+7.82%-- 
VTRSViatris12.96-0.22-1.67%227.2PE
HLNHaleon plc9.61+0.01+0.10%31.1PE
CGCCanopy Growth Corp4.24-0.31-6.81%-- 
Quotes are at least 15-min delayed:2024/11/10 18:36 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.